Novartis Investigative Site

Moss 1538

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease and Lipoprotein(a), Giant Cell Arteritis (GCA), Non-radiographic Spondyloarthritis

Studies at this site

• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) — Completed
• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed